CleanCap Reagent GG |
Katalog-Nr.GN20151
One-Click Copy Product Info
|
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
CleanCap Reagent GG is designed for the cotranscriptional capping of mRNA to produce an mRNA with naturally occurring Cap 1. Cap 1 mRNAs have superior in vivo activity compared to Cap 0 mRNA produced by legacy capping methods such as mCap or anti-reverse cap analog (ARCA).
CleanCap can be used in conjunction with GlpBio's catalog of modified NTPs.
Using the recommended conditions, transcription with CleanCap GG results in 70-90% capped material, generating a Cap 1 structure and gives crude yields of ~1.5 mg per mL of transcription. Final capping is dependent upon the DNA template and final mRNA sequence. Secondary structure due to RNA length and base composition can affect final capping efficiency.
| purity | >95.00%|>95.00% | Extinction Coefficient | 31,700 Lmol-1cm-1 at 260 nm |
| Formula | C32H45N15O25P4 (free acid) | M.Wt | 1175.7 g/mole (free acid) |
| Salt Form | Na+ | Konzentration | 50 mM |
| Buffer | H2O | Storage | -20°C or below |
| Überlieferungen | CleanCap Reagent GG for co-transcriptional capping of mRNA, m7G(5')ppp(5')(2'OMeG)pG | Backbone | 5'-5'-Triphosphate |
| Base Analog | Guanosine | Sugar Type | RNA |
| Nucleotide Category | Cap analogs | ||
| Anwendungen | CRISPR, In vitro Transcription, Recombinases, TALENS, Transposases, Vaccine Development | ||
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)